Physician profile
Andreas Sauerbrey
NPI 1568495729
$10,532.48
in general payments reported to CMS, 2019-2025
10 companies · $4,256 in 2025
The $4,256 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,095 · 2021: $508 · 2022: $2,996 · 2023: $1,371 · 2024: $307 · 2025: $4,256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,982 · Food and Beverage: $2,951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,982.36 |
| Food and Beverage | $2,950.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $8,551.36 | 2019-2025 | |
| Gemini Mountain Medical, LLC | $1,139.75 | 2025 | |
| Stryker Corporation | $591.38 | 2021-2025 | Axsos, T2 Alpha, Accolade |
| Arthrosurface Incorporated | $76.99 | 2019 | |
| Smith+Nephew, INC. | $55.63 | 2019-2024 | Healicoil, Firstpass, Q-Fix |
| Depuy Synthes Sales INC. | $36.53 | 2021-2024 | Monovisc, Orthovisc |
| Ossur Americas, INC. | $25.23 | 2025 | Unloader One X |
| Djo, LLC | $21.63 | 2024 | Cmf |
| Bioventus LLC | $21.56 | 2025 | Durolane |
| Conetic Solutions, INC. | $12.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andreas Sauerbrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.